CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

被引：0

作者：

Harrison, Stephen A. ^{[1
]}

Lawitz, Eric J. ^{[2
]}

Wong, Vincent Wai-Sun ^{[3
]}

Anstee, Quentin M. ^{[4
]}

Trauner, Michael H. ^{[5
]}

Romero-Gomez, Manuel ^{[6
]}

Bhandari, Bal ^{[7
]}

Abdelmalek, Manal F. ^{[8
]}

Sanyal, Arun J. ^{[9
]}

Patel, Keyur ^{[10
]}

Leroy, Vincent ^{[11
]}

Bureau, Christophe ^{[12
]}

Sasso, Magali ^{[13
]}

Fournier, Celine D. ^{[13
]}

Sandrin, Laurent ^{[13
]}

Han, Ling ^{[14
]}

Li, Georgia ^{[14
]}

Kersey, Kathryn ^{[14
]}

Camargo, Marianne ^{[14
]}

Djedjos, Stephen ^{[14
]}

Myers, Robert P. ^{[14
]}

Goodman, Zackary ^{[15
]}

Younossi, Youssef ^{[16
]}

机构：

[1] Pinnacle Clin Res, San Antonio, TX USA

[2] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[5] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria

[6] Univ Seville, Virgen Del Rocio Univ Hosp, Digest Dis Dept, Ciberehd,Seliver Grp,IBIS, Seville, Spain

[7] Delta Res Partners, Bastrop, LA USA

[8] Duke Univ, Durham, NC 27706 USA

[9] Virginia Commonwealth Univ, Richmond, VA 23284 USA

[10] Univ Hlth Network, Toronto, ON, Canada

[11] Grenoble Univ Hosp, Hepatol Dept, Grenoble, France

[12] CHU Toulouse, Toulouse, France

[13] Echosens, Paris, France

[14] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[15] Inova Fairfax Hosp, Falls Church, VA USA

[16] Inova Hlth Syst, Falls Church, VA USA

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2295

引用

页码：1349A / 1350A

页数：2

共 50 条

[31] A novel noninvasive diagnostic method for nonalcoholic steatohepatitis (NASH) using two glycobiomarkers
Kamada, Yoshihiro
Ono, Masafumi
Hyogo, Hideyuki
Fujii, Hideki
Sumida, Yoshio
Mori, Kohjiroh
Tanaka, Saiyu
Yamada, Makoto
Akita, Maaya
Mizutani, Kayo
Fujii, Hironobu
Yamamoto, Akiko
Takamatsu, Shinji
Yoshida, Yuichi
Itoh, Yoshito
Kawada, Norifumi
Chayama, Kazuaki
Saibara, Toshiji
Takehara, Tetsuo
Miyoshi, Eiji
HEPATOLOGY, 2015, 62 : 1258A - 1259A
[32] ASSESSING THE USE OF NONINVASIVE BIOMARKERS IN DRUG DEVELOPMENT FOR NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH).
Tian, X.
Li, S.
Kim, I.
Saluja, B.
Doddapaneni, S.
Sahajwalla, C.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S30 - S30
[33] Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
Verhaegh, Pauline
Bavalia, Roisin
Winkens, Bjorn
Masclee, Ad
Jonkers, Daisy
Koek, Ger
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 837 - 861
[34] Orlistat Reverse Fatty Infiltration and Improves Hepatic Fibrosis in Obese Patients with Nonalcoholic Steatohepatitis (NASH)
Osamah Hussein
Masha Grosovski
Sorina Schlesinger
Sergio Szvalb
Nimer Assy
Digestive Diseases and Sciences, 2007, 52 : 2512 - 2519
[35] ADIPOHORMONES AS PROGNOSTIC MARKERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
Krawczyk, K.
Szczesniak, P.
Kumor, A.
Jasinska, A.
Omulecka, A.
Pietruczuk, M.
Orszulak-Michalak, D.
Sporny, S.
Malecka-Panas, E.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 71 - 75
[36] MACHINE LEARNING FIBROSIS MODELS BASED ON LIVER HISTOLOGY IMAGES ACCURATELY CHARACTERIZE THE HETEROGENEITY OF CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
Younossi, Zobair M.
Pokkalla, Harsha
Pethia, Kishalve
Glass, Benjamin
Kerner, Jennifer Kaplan
Gindin, Yevgeniy
Han, Ling
Huss, Ryan
Chung, Chuhan
Djedjos, Stephen
Subramanian, Mani
Myers, Robert P.
Khosla, Aditya
Resnick, Murray
Harrison, Stephen A.
Anstee, Quentin M.
Wong, Vincent Wai-Sun
Wapinski, Ilan
Beck, Andrew
Goodman, Zachary D.
HEPATOLOGY, 2019, 70 : 1033A - 1034A
[37] Validation of Fractional Synthesis Rate of Plasma Lumican As a Noninvasive Marker of Fibrogenesis in Patients with Nonalcoholic Steatohepatitis (NASH)
Loomba, Rohit
Lawitz, Eric J.
Gene, Edward J.
Ruane, Peter J.
Zhang, Jie
Wang, Lulu
Chen, Guang
McColgan, Bryan John
Chung, Chuhan
Subramanian, Mani
Myers, Robert P.
Middleton, Michael S.
Noureddin, Mazen
Harrison, Stephen A.
Li, Kelvin W.
Hellerstein, Marc
HEPATOLOGY, 2018, 68 : 986A - 986A
[38] Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
Del Ben, Maria
Overi, Diletta
Polimeni, Licia
Carpino, Guido
Labbadia, Giancarlo
Baratta, Francesco
Pastori, Daniele
Noce, Valeria
Gaudio, Eugenio
Angelico, Francesco
Mancone, Carmine
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
[39] A NOVEL DIAGNOSTIC INDEX (TUFTS NASH SCORE) PREDICTS LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
Lee, David
Rai, Puja
Seo, Dong Joo
Fan, Gregory Hongyuan
Malik, Raza
HEPATOLOGY, 2020, 72 : 889A - 890A
[40] Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)
Hussein, Osamah
Grosovski, Masha
Schlesinger, Sorina
Szvalb, Sergio
Assy, Nimer
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (10) : 2512 - 2519

← 1 2 3 4 5 →